glp-1 agonists contraindications Incretins: How we got here, where we're at and what is coming next GLP-1 Receptor Agonists as Treatments
Description
This product is not intended to diagnose, treat, cure, or prevent any disease
Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity
Author's Bio: Katie Bailey, MS, RD, LD, FNCHi everyone
The fascinating history of the GLP-1 drugs- Ozempic, Wegovy, and Mounjaro.
Due to the bodys natural tendency to restore its former weight, many people regain their lost weight when they stop using GLP-1 drugs.
